Ethical Responsibilities of a Globalized Medical System
summary
Claims that genome sequencing now costs about $1,000 and that lung cancer is already split into ~20 genetic subtypes are backed by concrete outcomes: EGFR-mutant patients see survival rise from ~8 to ~30 months with an oral pill, databases already aggregate ~160,000 patient records, and big data pipelines link clinical plus genomic feeds. Global burden is concrete too: ~14 million current cases, projected ~22 million (a ~70% rise) with ~70% of deaths in low-access regions while some therapies run ~$12,000/month or >$100,000/year, creating clear ethical and political pressure for price negotiations and global access mechanisms.
AI-written summary · about
chapters (12)
- 0:00Intro
- 1:00Complexity
- 2:49Signaling Networks
- 4:31Human Genome and Cancer
- 6:03Precision Medicine
- 8:15Big Data
- 10:45Ethical conflicts
- 12:46Summary
- 13:17Future of cancer treatment
- 15:45Taking care of the patient
- 17:32Politics
- 21:00Theology or Medicine
related talks
14mAugmenting Human Capabilities to New Dimensions
32mQualify for the Future: Does Digitalization Make the World a Better Place?
48mAn Ethical Crisis in Computing?
34mThe ethics of data: Privacy vs. personalization
12mIt's Only the Beginning – Albert Wenger
24mWe owe it to humanity to push boundaries
29mDesigning for humanity
23mSurveillance Capitalism: Do We Need A New Social Contract